Niagen Bioscience Inc share price logo

Niagen Bioscience Inc Share Price

NASDAQ: NAGE

Small Cap

$5.22

+0.11

(+2.25%)

as on

Niagen Bioscience Inc Stock Performance

as on March 11, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $5.07
    $5.39
    downward going graph

    2.87%

    Downside

    3.26%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $4.73
    $14.69
    downward going graph

    9.48%

    Downside

    181.42%

    Upside

    downward going graph

Niagen Bioscience Inc share price movements today

Previous Close
$5.11
Open
$5.07
Volume
2.1M
Day's Low - High
$5.07 - $5.39
52 Week Low - High
$4.73 - $14.69

Niagen Bioscience Inc Historical Returns

1 Month Return
+ 2.15 %
3 Month Return
-21.27 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Niagen Bioscience Inc Stock Fundamentals & Key Indicators

Check Niagen Bioscience Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$409.2M

EPS (TTM)

0.265

Dividend Yield

0.00%

PE Ratio (TTM)

25.55

Industry PE ratio

0

PEG Ratio

0

Return On Equity TTM

28.35%

Niagen Bioscience Inc Stock Valuation

Track how Niagen Bioscience Inc P/E has moved over time to understand its valuation trends.

Niagen Bioscience Inc in the last 5 years

  • Overview

  • Trends

Lowest (39.17x)

December 31, 2025

Industry (0.00x)

March 11, 2026

Today (25.55x)

March 11, 2026

Highest (47.02x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 25.55x

Niagen Bioscience Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Niagen Bioscience Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Niagen Bioscience Inc image
Niagen Bioscience Inc
NA$409.2MNA25.5513.43%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$42.9B125.47%138.888.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$117.1B132.01%30.1232.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$34.9BNA121.895.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$82.6B64.28%18.8331.41%

Niagen Bioscience Inc Stock’s Investor Sentiment and Interest

Search interest for Niagen Bioscience Inc Stock has increased by 57% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:57% versus previous 30 day period

Niagen Bioscience Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
19
21
22
22
25
29
30
31
33
33
Gross Profit
11
12
13
13
16
18
19
20
21
21
Operating Income
-1
0
0
0
1
7
4
3
4
2
EBITDA
0
0
0
0
1
7
5
3
4
2
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
0
0
0
0
1
7
5
3
4
4
Income Tax Expense
-
-
-
-
-
0
0
0
0
0
Net Income
0
0
0
0
1
7
5
3
4
4
Net Profit Margin
-4.92%
0.54%
-2.22%
-0.07%
7.34%
24.65%
16.61%
11.60%
13.47%
12.21%

Niagen Bioscience Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
21
21
31
46
59
67
72
83
99
129
Gross Profit
10
10
16
25
35
41
42
50
61
83
Operating Income
-2
-16
-33
-31
-19
-27
-18
-5
7
14
EBITDA
-2
-15
-32
-29
-18
-25
-16
-3
9
15
Interest Expense
0
0
0
0
0
0
-
-
-
-
Depreciation
-
-
-
-
-
1
1
1
1
1
Income Before Tax
-3
-16
-33
-32
-19
-27
-16
-4
8
18
Income Tax Expense
-
-
-
-
-
-
-
-
0
0
Net Income
-2
-11
-33
-32
-19
-27
-16
-4
8
17
Net Profit Margin
-13.52%
-53.67%
-105.57%
-69.45%
-33.62%
-40.22%
-22.96%
-5.91%
8.58%
13.43%

Niagen Bioscience Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
0
0
0
1
7
5
3
4
4
Operating Cash Flow
0
0
0
3
8
7
1
3
0
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
0
0
1
3
3
3
0
0
Change in Cash
0
0
0
4
12
10
4
3
0

Niagen Bioscience Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-11
-33
-32
-19
-27
-16
-4
8
17
Operating Cash Flow
-9
-20
-20
-10
-24
-15
7
12
13
Investing Cash Flow
4
-1
0
0
0
0
0
0
0
Financing Cash Flow
48
0
16
8
36
7
0
5
6
Change in Cash
43
-22
-3
-2
11
-7
6
17
20

Insights on Niagen Bioscience Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, NAGE has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, NAGE stock has moved up by 5.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.0% return, outperforming this stock by 68.9%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 4.57M → 4.13M (in $), with an average decrease of 9.7% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 33.98M → 33.83M (in $), with an average decrease of 0.4% per quarter

About Niagen Bioscience Inc

Niagen Bioscience, Inc. specializes in nicotinamide adenine dinucleotide (NAD+) science and healthy-aging research. At the center of its clinically proven product portfolio is Niagen (patented nicotinamide riboside or NR). Niagen powers its consumer supplement, Tru Niagen, a NAD+ boosting oral supplement in the United States, and Niagen Plus, featuring pharmaceutical-grade intravenous and injectable Niagen products. Its segments include Consumer Products, Ingredients, and Analytical Reference Standards and Services. Consumer Products segment provides finished dietary supplement products containing its proprietary ingredients directly to consumers and distributors, as well as NAD+ test kits exclusively to healthcare practitioners. Ingredients segment develops and commercializes proprietary-based ingredient technologies. Analytical Reference Standards and Services segment is focused on natural product fine chemicals, known as phytochemicals, and related research and development services.
OrganisationNiagen Bioscience Inc
Headquarters10900 Wilshire Blvd, Los Angeles, CA, United States, 90024
CEOMr. Robert N. Fried
E-voting on sharesClick here to vote

Key Management of Niagen Bioscience Inc

Name

Title

Mr. Ozan Pamir C.F.A.

CFO & Principal Accounting Officer

Mr. James Lee

Controller

Ms. Michiko Kelley

Chief Marketing Officer

Kendall Knysch

Head of Media Relations & Partnerships

Mr. Frank Louis Jaksch Jr.

Co-Founder & Chairman

Mr. Robert N. Fried

CEO & Director

Ms. Chu Yan

Managing Director of Asia Pacific

Wesley Yu

Vice President of Finance

Mr. Carlos Lopez

Senior VP & General Counsel

Dr. Andrew Shao Ph.D.

Senior Vice President of Global Regulatory & Scientific Affairs

FAQs

What is Niagen Bioscience Inc share price today?

Niagen Bioscience Inc share price today is $5.22 as on at the close of the market. Niagen Bioscience Inc share today touched a day high of $5.39 and a low of $5.07.

What is the 52 week high and 52 week low for Niagen Bioscience Inc share?

Niagen Bioscience Inc share touched a 52 week high of $14.69 on and a 52 week low of $4.73 on . Niagen Bioscience Inc stock price today i.e. is closed at $5.22,which is 64.47% down from its 52 week high and 10.48% up from its 52 week low.

What is Niagen Bioscience Inc's market capitalisation today?

Niagen Bioscience Inc market capitalisation is $0.00T as on .

How to invest in Niagen Bioscience Inc Stock (NAGE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Niagen Bioscience Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Niagen Bioscience Inc Shares that will get you 0.2874 shares as per Niagen Bioscience Inc share price of $5.22 per share as on March 11, 2026 at 1:29 am IST.

What is the minimum amount required to buy Niagen Bioscience Inc Stock (NAGE) from India?

Indian investors can start investing in Niagen Bioscience Inc (NAGE) shares with as little as ₹91.833 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹918.33 in Niagen Bioscience Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Niagen Bioscience Inc share’s latest price of $5.22 as on March 11, 2026 at 1:29 am IST, you will get 1.9157 shares of Niagen Bioscience Inc. Learn more about fractional shares .